COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

December 18, 2020

Study Completion Date

August 13, 2021

Conditions

Respiratory Distress Syndrome, Adult

Interventions

DRUG

Veru-111

Respiratory Distress Syndrome, Adult

Trial Locations (5)

Regions Hospital, Saint Paul

Methodist Hospital, Saint Louis Park

Memorial Hermann Memorial City Hospital, Houston

HonorHealth, Scottsdale

Inspira Medical Center, Vineland

All Listed Sponsors

lead

Veru Inc.

INDUSTRY

NCT04388826 - COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 | Biotech Hunter | Biotech Hunter